| Product Code: ETC9559890 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Motor Neurone Disease (MND) Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Motor Neurone Disease (MND) Market - Industry Life Cycle |
3.4 Sweden Motor Neurone Disease (MND) Market - Porter's Five Forces |
3.5 Sweden Motor Neurone Disease (MND) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Sweden Motor Neurone Disease (MND) Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Sweden Motor Neurone Disease (MND) Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Sweden Motor Neurone Disease (MND) Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.9 Sweden Motor Neurone Disease (MND) Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Sweden Motor Neurone Disease (MND) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about motor neurone disease (MND) in Sweden |
4.2.2 Advances in medical research leading to better diagnosis and treatment options |
4.2.3 Rising geriatric population in Sweden, which is a high-risk group for MND |
4.3 Market Restraints |
4.3.1 Limited availability of effective treatments for MND in Sweden |
4.3.2 High costs associated with the management and care of MND patients |
4.3.3 Lack of comprehensive support systems for MND patients and their families in Sweden |
5 Sweden Motor Neurone Disease (MND) Market Trends |
6 Sweden Motor Neurone Disease (MND) Market, By Types |
6.1 Sweden Motor Neurone Disease (MND) Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, By Amyotrophic lateral sclerosis (ALS), 2021- 2031F |
6.1.4 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, By Progressive bulbar palsy (PBP), 2021- 2031F |
6.1.5 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, By Progressive muscular atrophy (PMA), 2021- 2031F |
6.1.6 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, By Primary lateral sclerosis (PLS), 2021- 2031F |
6.2 Sweden Motor Neurone Disease (MND) Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, By Physiotherapy, 2021- 2031F |
6.2.4 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, By Palliative Care, 2021- 2031F |
6.2.5 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Sweden Motor Neurone Disease (MND) Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, By Blood test, 2021- 2031F |
6.3.3 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, By Electromyography (EMG), 2021- 2031F |
6.3.4 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, By MRI Scan, 2021- 2031F |
6.3.5 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, By Transcranial magnetic stimulation (TMS), 2021- 2031F |
6.3.6 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Sweden Motor Neurone Disease (MND) Market, By Dosage |
6.4.1 Overview and Analysis |
6.4.2 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, By Tablet, 2021- 2031F |
6.4.3 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, By Injection, 2021- 2031F |
6.4.4 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Sweden Motor Neurone Disease (MND) Market, By End users |
6.5.1 Overview and Analysis |
6.5.2 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5.4 Sweden Motor Neurone Disease (MND) Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden Motor Neurone Disease (MND) Market Import-Export Trade Statistics |
7.1 Sweden Motor Neurone Disease (MND) Market Export to Major Countries |
7.2 Sweden Motor Neurone Disease (MND) Market Imports from Major Countries |
8 Sweden Motor Neurone Disease (MND) Market Key Performance Indicators |
8.1 Average time to diagnosis for MND patients in Sweden |
8.2 Number of clinical trials focused on MND treatment in Sweden |
8.3 Percentage of MND patients in Sweden receiving multidisciplinary care |
8.4 Patient satisfaction scores with MND support services in Sweden |
8.5 Number of healthcare professionals specializing in MND care in Sweden |
9 Sweden Motor Neurone Disease (MND) Market - Opportunity Assessment |
9.1 Sweden Motor Neurone Disease (MND) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Sweden Motor Neurone Disease (MND) Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Sweden Motor Neurone Disease (MND) Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Sweden Motor Neurone Disease (MND) Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.5 Sweden Motor Neurone Disease (MND) Market Opportunity Assessment, By End users, 2021 & 2031F |
10 Sweden Motor Neurone Disease (MND) Market - Competitive Landscape |
10.1 Sweden Motor Neurone Disease (MND) Market Revenue Share, By Companies, 2024 |
10.2 Sweden Motor Neurone Disease (MND) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here